Alyeska Investment Group’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6M | Buy |
2,075,882
+633,409
| +44% | +$1.83M | 0.02% | 398 |
|
|
2025
Q1 | $3.1M | Buy |
1,442,473
+458,396
| +47% | +$986K | 0.01% | 390 |
|
|
2024
Q4 | $3.81M | Buy |
984,077
+273,920
| +39% | +$1.06M | 0.01% | 415 |
|
|
2024
Q3 | $4.65M | Sell |
710,157
-111,530
| -14% | -$731K | 0.02% | 363 |
|
|
2024
Q2 | $5.96M | Buy |
821,687
+271,660
| +49% | +$1.97M | 0.03% | 313 |
|
|
2024
Q1 | $4.17M | Buy |
+550,027
| New | +$4.17M | 0.03% | 330 |
|
|
2022
Q4 | – | Sell |
-133,073
| Closed | -$426K | – | 468 |
|
|
2022
Q3 | $426K | Buy |
+133,073
| New | +$426K | 0.01% | 357 |
|
|
2018
Q3 | – | Sell |
-20,833
| Closed | -$2.56M | – | 431 |
|
|
2018
Q2 | $2.56M | Buy |
+20,833
| New | +$2.56M | 0.02% | 313 |
|
|
2016
Q3 | – | Sell |
-13,166
| Closed | -$946K | – | 484 |
|
|
2016
Q2 | $946K | Buy |
13,166
+267
| +2% | +$19.2K | 0.01% | 382 |
|
|
2016
Q1 | $1.03M | Sell |
12,899
-1,277
| -9% | -$102K | 0.01% | 348 |
|
|
2015
Q4 | $1.07M | Buy |
+14,176
| New | +$1.07M | 0.01% | 331 |
|
|
2015
Q1 | – | Sell |
-10,285
| Closed | -$3.81M | – | 515 |
|
|
2014
Q4 | $3.81M | Sell |
10,285
-294
| -3% | -$109K | 0.06% | 279 |
|
|
2014
Q3 | $2.5M | Sell |
10,579
-5,195
| -33% | -$1.23M | 0.05% | 260 |
|
|
2014
Q2 | $3.74M | Buy |
+15,774
| New | +$3.74M | 0.08% | 236 |
|